Spots Global Cancer Trial Database for recist
Every month we try and update this database with for recist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Evaluation for Sarcoma Originated From Bone | NCT03358992 | Sensitivity Specificity Histological Re... Survival | - | Peking University People's Hospital | ||
| Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging | NCT05254132 | Non Small Cell ... | Liquid biopsy | 18 Years - | OncoRadiomics | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom | NCT03413579 | Cervical Cancer | Nimotuzumab ( h... Placebo | 18 Years - 75 Years | El Kendi Pharmaceuticals Manufacturing Company | |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | NCT00558103 | Neoplasms, Brea... | lapatinib Pazopanib | 18 Years - | GlaxoSmithKline | |
| A Study of NPX887 for Participants With Solid Tumors Known to Express HHLA2/B7-H7 | NCT06240728 | Metastatic Mali... | NPX887 | 18 Years - | NextPoint Therapeutics, Inc. | |
| HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas | NCT05180695 | Advanced Soft-t... Metastatic Soft... | Pazopanib HDM201 | 18 Years - | Centre Leon Berard | |
| Role of Perfusion CT in Pancreatic Cancer | NCT01703650 | Adenocarcinoma,... Neuroendocrine ... | iopromide CT | 18 Years - | Seoul National University Hospital | |
| Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer | NCT00443573 | Colon Cancer | recombinant nem... | 18 Years - 75 Years | ARCA Biopharma, Inc. | |
| Clinical Evaluation for Sarcoma Originated From Bone | NCT03358992 | Sensitivity Specificity Histological Re... Survival | - | Peking University People's Hospital | ||
| HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas | NCT05180695 | Advanced Soft-t... Metastatic Soft... | Pazopanib HDM201 | 18 Years - | Centre Leon Berard | |
| Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization | NCT04780789 | Hepatocellular ... Hepatocellular ... | Transarterial C... | 18 Years - | Brno University Hospital | |
| Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer | NCT04882371 | Breast Cancer Chemotherapy Ef... | Chemotherapy Magnetic Resona... Positron emissi... | 18 Years - | Istanbul Medeniyet University | |
| Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization | NCT04780789 | Hepatocellular ... Hepatocellular ... | Transarterial C... | 18 Years - | Brno University Hospital | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | NCT00558103 | Neoplasms, Brea... | lapatinib Pazopanib | 18 Years - | GlaxoSmithKline | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | NCT05735717 | Hematologic Mal... Acute Leukemia Remission Acute Myeloid L... Acute Lymphobla... AML TP53 Intrachromosoma... Cytogenetic Abn... CNS Leukemia Minimal Residua... Myelodysplasia Juvenile Myelom... Somatic Mutatio... PTPN11 Gene Mut... N-RAS Gene Ampl... Neurofibromatos... NF1 Mutation CBL Gene Mutati... Monosomy 7 Chromosome Abno... Fetal Hemoglobi... | Fludarabine Busulfan Melphalan Rituximab Levetiracetam | - 60 Years | Masonic Cancer Center, University of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
